-
Voting Rights and Shares Capital of the Company
17 Dec 2025 21:15 GMT
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Dec. 17, 2025 (GLOBE NEWSWIRE) --
Market: Euronext Paris / …
-
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
17 Dec 2025 21:30 GMT
… the 2026 Annual Meeting of Stockholders; Proposal No. 2: The … of the Reverse Share Split and Share Consolidation of the … “Cellyan Biotechnology Co., Ltd” and the Company’s foreign name be … anticipated results and encourages investors to review other factors …
-
Tether Leads Investment in Speed to Enable Lightning Native, Stablecoin based Payments
17 Dec 2025 20:54 GMT
… fees, strong compliance, and global reach.”
Speed integrates with the … Its portfolio includes investments in “artificial intelligence, financial services, energy, biotechnology, education, and … in both emerging and developed markets.”
Its work supports Tether …
-
5 Biotech Stocks to Watch for Potential Upside
17 Dec 2025 20:52 GMT
… will continue to capture investors’ interest going forward … comprises biopharmaceutical and biotechnology companies that develop … crucial to improving global health, biotech companies … Stock Analysis Report
This article originally published on Zacks Investment …
-
EU unveils new biotech plan to boost its global competitiveness and close gap with China, US
17 Dec 2025 19:54 GMT
… a framework that helps biotechnology reach the market faster, … again a global powerhouse by creating an industrial, financial, and … health‑biotech venture capital investment in the United States … national schemes, and public investors. The goal is to …
-
Global Market Report on Histidine Tag (His-Tag) Antibodies 2025 | Business Expansion, and Trends from Present to 2029
17 Dec 2025 15:30 GMT
… .com/report/global-histidine-tag-his-tag-antibody … North America held the largest share of the histidine tag (His … forecast period, driven by increasing investments in biotechnology research, expanding pharmaceutical manufacturing …
-
ARE STOCK NOTICE: Alexandria Real Estate Equities, Inc. Faces Securities Fraud Class Action after 19% Stock Drop – Investors with Losses Urged to Contact BFA Law
17 Dec 2025 14:07 GMT
… -class-action-lawsuit. Investors have until January 26 … is a real estate investment trust. Its tenants … such as pharmaceutical and biotechnology companies. During the … international law firm representing plaintiffs in securities class actions and shareholder …
-
EMMA International Honored with EurAsia Gulf Excellence Award for Advancing Healthcare Quality Standards
17 Dec 2025 13:43 GMT
… improvement programs, financial advisory services, and guidance for investors entering the region … International is a leading global consulting firm for the medical device, pharmaceutical, biotechnology …
-
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
17 Dec 2025 12:45 GMT
… , continuously enhancing shareholder value through sustained … global footprint by strengthening partnerships with research institutions, international … #47;
CONTACT: Investor and Media Contact
…
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE …
-
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
17 Dec 2025 12:20 GMT
JUPITER, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, …
About
© 1995-2025